Home » Newsletters » BioWorld Science

BioWorld Science

March 29, 2010

View Archived Issues

Dr. Reddy's Laboratories claims new globin transcription factor activators

Merck & Co. discovers new calcitonin receptor CGRP antagonists

Merck Serono discovers Aurora kinase inhibitors for cancer therapy

GlaxoSmithKline claims new antiviral agents for hepatitis C virus infection

Elan discloses novel gamma-secretase inhibitors

New GSK-3 autophosphorylation inhibitor shows preclinical promise in neuroregeneration after injury

Phase II data presented on PROSTVAC-VF immunotherapy in metastatic CRPC

Novartis identifies a new class of potent antimalarials

Betrixaban compares well with warfarin in phase II trial in nonvalvular atrial fibrillation

PLATO substudies assess effects of ticagrelor on arrhythmias and pulmonary function

Flurpiridaz F18 PET detects coronary artery disease with more specificity than [99mTc] SPECT

Ablynx advances inhalable ALX-0171 to preclinical studies for RSV infections

Aradigm completes enrollment in phase II trial of inhaled ciprofloxacin in bronchiectasis

BioSeek and Ono initiate new multiyear drug discovery collaboration

BioAlliance obtains approval for Loramyc in 13 additional European countries

Oramed completes phase IIb trial of oral insulin capsule ORMD-0801 for type 2 diabetes

FDA sets advisory committee review date for Vivus' Qnexa NDA for obesity

Cortex Pharmaceuticals sells selected Ampakine compounds to Biovail

Novelos begins enrollment in phase II trial of NOV-205 in hepatitis C

Traversa and sanofi-aventis to collaborate on development RNAi delivery technology

Bayer to update label for oral contraceptive Yasmin in E.U.

Merck KGaA receives approval for extended use of Erbitux in Japan

Rotarix vaccine not a threat to public safety states EMA

New safety information for ITP therapeutic WinRho(R) SDF in Canada

FDA approves Graceway's Zyclara NDA for actinic keratoses

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...